Loading...
XASX
ADO
Market cap33mUSD
Jul 31, Last price  
0.02AUD
1D
11.76%
1Q
137.50%
Jan 2017
-51.50%
IPO
-99.36%
Name

Anteotech Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
111.64
EPS
—
Div Yield, %
—
Shrs. gr., 5y
13.21%
Rev. gr., 5y
10.75%
Revenues
460k
+25.89%
1,991,478809,6041,856,6421,135,464674,615265,752210,063405,175510,294309,759468,7822,391,1252,471,559981,319276,313299,403898,067760,875365,724460,397
Net income
-9m
L-29.82%
-1,579,539-6,245,124-1,563,497-1,762,317-1,949,275-2,240,249-2,222,462-2,380,199-2,179,223-2,492,150-4,253,463-6,914,664-7,005,505-3,385,384-3,296,840-3,126,563-6,215,584-10,716,808-12,654,256-8,880,517
CFO
-7m
L-19.33%
00000000-2,270,754-1,976,666-3,366,231-7,159,295-340,669-4,512,184-2,343,530-2,501,902-4,549,298-8,653,389-8,083,171-6,520,976

Profile

AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
URL
https://www.anteotech.com/
IPO date
Apr 11, 2000
Employees
24
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
460
25.89%
366
-51.93%
Cost of revenue
12,187
12,591
Unusual Expense (Income)
NOPBT
(11,727)
(12,225)
NOPBT Margin
Operating Taxes
(3,200)
Tax Rate
NOPAT
(11,727)
(9,025)
Net income
(8,881)
-29.82%
(12,654)
18.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
10,515
1,847
BB yield
-23.50%
-2.31%
Debt
Debt current
623
648
Long-term debt
3,998
1,317
Deferred revenue
Other long-term liabilities
594
523
Net debt
(434)
(755)
Cash flow
Cash from operating activities
(6,521)
(8,083)
CAPEX
(1,059)
(691)
Cash from investing activities
(1,059)
(691)
Cash from financing activities
9,885
1,391
FCF
(13,404)
(7,231)
Balance
Cash
5,025
2,720
Long term investments
30
Excess cash
5,032
2,702
Stockholders' equity
5,306
2,377
Invested Capital
3,179
1,829
ROIC
ROCE
EV
Common stock shares outstanding
2,237,397
2,002,901
Price
0.02
-50.00%
0.04
-38.46%
Market cap
44,748
-44.15%
80,116
-37.63%
EV
44,314
79,361
EBITDA
(10,687)
(11,227)
EV/EBITDA
Interest
43
31
Interest/NOPBT